Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2073 - 2080 of 11616 results
A Brief Summary of the SEC’s Proposed Climate-Related Rules
March 30, 2022| Advisory| Viewpoint
ML Strategies Energy & Sustainability Washington Update — April 2022
March 30, 2022| Blog| Viewpoint
Department of Homeland Security Designates Ukraine and Afghanistan for TPS
March 29, 2022| Alert| Viewpoint
PBM Regulatory Roundup (Spring 2022): The 8th Circuit Rules and More States Issue Regulations
March 29, 2022| Blog| Viewpoint
USCIS Conducts Lottery Selection Process for H-1B FY2023 Cap
March 28, 2022| Alert| Viewpoint
Federal Healthcare Agencies Aim to Prioritize Information Blocking Enforcement in 2022
March 28, 2022| Blog| Viewpoint
Six Common Contract Traps: A Field Guide
March 25, 2022| Advisory| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.